Search Results 271-280 of 16019 for pharmacogenetics
Minimal residual disease (MRD) detection using circulating tumor DNA (ctDNA). MRD detection from proximal biofluids to anticipate cancer relapse.
Niloy Jewel Samadder, M.D.. “While the overall incidence of disease progression was not lower, the combination therapy of the drugs sulindac and eflornithine ...
The purpose of the study is to learn more about autoimmunity and potential mother to baby transmission of pathogenic antibodies. The collected research samples ...
The purpose of this study is to build a Mayo Clinic registry of data and biobank from subjects with drug allergy. The data collected will include demographic, ...
The purpose of this study is to determine safety of plasma infusion in APOE 44 patients. Participation eligibility. Participant eligibility includes age, gender ...
About this study. Some patients with head and neck cancer caused by human papilloma virus have a higher risk of recurrence. We are proposing to treat these ...
About this study. The purpose of this study is to establish the prevalence and severity of specific morbid indicators of disease severity such as specific ...
Mayo Clinic neurology experts are presenting research findings on Parkinson's disease, Alzheimer's disease, sleep disorders, concussions, multiple sclerosis and ...
Learn how Dr. Ling's Phospholipid Signaling in Embryonic Development and Human Diseases Lab at Mayo Clinic studies the roles of phosphoinositide species and ...
Polygenic risk · Heart palpitations. · Irregular heart rhythm or rate. · A feeling of skipped beats or irregular beats that last for a few seconds or more.
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Your GivingTuesday gift can go 2X as far.